Scarica l'app Stockscreener
1.18
4.07%
-0.05
Dopo l'orario di chiusura:
1.16
-0.02
-1.69%
Precedente Chiudi:
$1.23
Aprire:
$1.23
Volume 24 ore:
679.83K
Relative Volume:
1.20
Capitalizzazione di mercato:
$136.02M
Reddito:
-
Utile/perdita netta:
$-26.33M
Rapporto P/E:
-4.1785
EPS:
-0.2824
Flusso di cassa netto:
$-17.65M
1 W Prestazione:
-2.48%
1M Prestazione:
+14.56%
6M Prestazione:
+13.46%
1 anno Prestazione:
-15.71%
Intervallo 1D:
$1.15
$1.25
Intervallo di 1 settimana:
$1.15
$1.32
Portata 52W:
$0.88
$1.71
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.18 | 136.02M | 0 | -26.33M | -17.65M | -0.2824 |
TAK
Takeda Pharmaceutical Co Adr
|
17.24 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.78 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.81 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.35 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
528.47 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-06-26 | Iniziato | ROTH MKM | Buy |
| 2024-04-22 | Iniziato | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Borsa (CRDL) Ultime notizie
TradingKey - TradingKey
Cardiol Therapeutics Inc. Class A Revenue Breakdown – SWB:CT9 - TradingView
Why Cardiol Therapeutics Inc Class A stock is sliding today - Wealth Awesome
Cardiol Therapeutics (CRDL) Gains 4.13% as Bullish Momentum Builds Above $1.23 SupportDouble EMA - dars.gov.et
What's Going On With Cardiol Therapeutics Inc Class A Stock Monday? - Wealth Awesome
CRDL Stock Price, Quote & Chart - ChartMill
Why Cardiol Therapeutics Inc Class A stock is skyrocketing today - Wealth Awesome
Cardiol Therapeutics (TSX:CRDL) Expands Visibility Across Healthcare Sector - Kalkine Media
Why Cardiol Therapeutics Inc Class A stock is rising today - Wealth Awesome
Cardiol Therapeutics Publishes Recurrent Pericarditis Phase II Data - t.co
H.C. Wainwright reiterates Cardiol Therapeutics stock Buy rating at $9 By Investing.com - Investing.com Nigeria
Cardiol Therapeutics’ Phase II Pericarditis Data in JAHA Bolsters Near-Complete Phase III MAVERIC Trial - TipRanks
Cardiol Publishes Phase II MAVERIC Data in the Journal of the American Heart Association - the deep dive
Cardiol publishes phase II pericarditis study in medical journal By Investing.com - Investing.com South Africa
CRDL Reiterated by HC Wainwright & Co. -- Price Target Maintained at $9 - GuruFocus
What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday? - Wealth Awesome
Cardiol Therapeutics Inc. - Baystreet.ca
Cardiol publishes phase II pericarditis study in medical journal - Investing.com
Cardiol Therapeutics (NASDAQ: CRDL) publishes Phase II pericarditis data as Phase III nears full enrollment - Stock Titan
Stocks in play: Cardiol Therapeutics Inc. - Barchart.com
CRDL SEC FilingsCardiol Therapeu 10-K, 10-Q, 8-K Forms - Stock Titan
Cardiol Therapeutics (CRDL) to Attend B. Riley Securities Summit in Boston - GuruFocus
Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit - 富途牛牛
Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit - TipRanks
Cardiol Therapeutics (CRDL) to present CardiolRx™ pipeline at B. Riley Mind, Muscle & Vision Summit - Stock Titan
Why Cardiol Therapeutics Inc Class A stock is plummeting today - Wealth Awesome
ETFs Investing in Cardiol Therapeutics Inc. Class A Stocks - TradingView
Why Cardiol Therapeutics Inc Class A stock is gaining today - Wealth Awesome
Why Cardiol Therapeutics Inc Class A stock is tanking today - Wealth Awesome
CRDL Should I Buy - Intellectia AI
CRDL Q1 2026 Earnings: Narrower-than-Expected Loss as Cardiol Therapeutics Advances PipelineReturn On Equity - dars.gov.et
CRDL Q1 2026 Earnings: Narrower-Than-Expected Loss as Company Advances Clinical PipelineEstimate Uncertainty - DonanımHaber
CRDL Q1 2026 Earnings: Narrower-than-Expected Loss Signals Steady Clinical ProgressGAAP Earnings Report - dars.gov.et
Enterprise value to revenue forward of Cardiol Therapeutics Inc. – BOATS:CRDL - TradingView
Price to earnings forward of Cardiol Therapeutics Inc. Class A – TSX:CRDL - TradingView
Enterprise value to revenue forward of Cardiol Therapeutics Inc. Class A – TSX:CRDL - TradingView
Cardiol Therapeutics Inc. Class A Actuals & Estimates (TSX:CRDL) - TradingView
Cardiol Therapeutics Inc. Class A Actuals & Estimates (NEO:CRDL) - TradingView
CRDL Forecast — Price Target — Prediction for 2027 - TradingView
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM - TipRanks
A2PA9E Forecast — Price Target — Prediction for 2027 - TradingView
Strong shareholder support at Cardiol Therapeutics (CRDL) 2026 AGM as all directors elected - Stock Titan
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders - Finansavisen
Cardiol Therapeutics (CRDL) Q1 2026 Earnings: Narrower Loss Per Share Amid Clinical ProgressProfit Guidance Range - dars.gov.et
Cardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance - TipRanks
Form 6K Cordel Group PLC For: 23 June By Investing.com - Investing.com India
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT - PR Newswire
Cardiol Therapeutics Inc (CRDL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardiol Therapeutics Inc (CRDL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardiol Therapeutics Inc (CRDL) Institutional Confidence - TradingKey
Cardiol Therapeutics Inc Azioni (CRDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):